CAP taps Wagner

Jeff Byers | | Health Exec | Precision Medicine

The College of American Pathologists (CAP) has hired Charles Wagner as vice president of its STS (SNOMED Terminology Solutions) division. Wagner will lead CAP STS’ professional services expansion in the health IT marketplace.

In his new position, Wagner will help the Northfield, Ill.-based CAP STS build new services targeted to CAP members and lead business development in the health IT community. These initiatives will also help support the CAP’s transformation efforts under way to foster new roles for pathologists as critical members of the patient care team.

Prior to joining CAP STS, Wagner was managing director of U.S. Healthcare Operations and Global Healthcare Application Delivery at Dell Services, CAP stated.

Jeff Byers

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”